These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9528984)

  • 1. Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog.
    Campbell MJ; Park S; Uskokovic MR; Dawson MI; Koeffler HP
    Endocrinology; 1998 Apr; 139(4):1972-80. PubMed ID: 9528984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid.
    Campbell MJ; Park S; Uskokovic MR; Dawson MI; Jong L; Koeffler HP
    Br J Cancer; 1999 Jan; 79(1):101-7. PubMed ID: 10408700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
    de Vos S; Holden S; Heber D; Elstner E; Binderup L; Uskokovic M; Rude B; Chen DL; Le J; Cho SK; Koeffler HP
    Prostate; 1997 May; 31(2):77-83. PubMed ID: 9140119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
    Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
    J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.
    Campbell MJ; Elstner E; Holden S; Uskokovic M; Koeffler HP
    J Mol Endocrinol; 1997 Aug; 19(1):15-27. PubMed ID: 9278857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
    Fanjul AN; Bouterfa H; Dawson M; Pfahl M
    Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
    Lou YR; Miettinen S; Kagechika H; Gronemeyer H; Tuohimaa P
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1973-81. PubMed ID: 16289102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.
    Blutt SE; Allegretto EA; Pike JW; Weigel NL
    Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
    Lotan R
    Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.
    Murthy S; Marcelli M; Weigel NL
    Prostate; 2003 Sep; 56(4):293-304. PubMed ID: 12858358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.